Answer
Preclinical data indicate that small amounts of moxifloxacin are secreted in milk; human lactation data are unavailable, and breastfeeding is contraindicated during moxifloxacin therapy because of this absence and the experimental risk of fluoroquinolone damage to immature animals’ weight-bearing cartilage.
Sources for this answer
- Avelox 400 mg film-coated tabletsBayer plc · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 29Document updated
Sources checked